Sectoral Asset Management
Latest statistics and disclosures from Sectoral Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are FOLD, Aerie Pharmaceuticals, ALNY, Apellis Pharmaceuticals Inc, Teladoc, and represent 22.76% of Sectoral Asset Management's stock portfolio.
- Added to shares of these 10 stocks: Shockwave Med Inc (+$28.44M), Sarepta Therapeutics (+$15.27M), MRK (+$13.70M), Allergan (+$12.43M), Assembly Biosciences (+$10.99M), Ptc Therapeutics I (+$8.64M), Evolent Health (+$7.74M), Forty Seven Inc (+$7.54M), HMSY (+$7.17M), D Stemline Therapeutics (+$7.16M).
- Started 13 new stock positions in Inspire Med Sys Inc, Agios Pharmaceuticals, Urogen Pharma, Biohaven Pharmaceutical Holding, Myokardia, MRK, Forty Seven Inc, Glycomimetics, Allergan, Sarepta Therapeutics. Spark Therapeutics, Fibrogen, Shockwave Med Inc.
- Reduced shares in these 10 stocks: ARRY (-$30.62M), FOLD (-$22.33M), CELG (-$20.50M), IMMU (-$18.57M), Aerie Pharmaceuticals (-$13.96M), ALNY (-$9.75M), Apellis Pharmaceuticals Inc (-$8.59M), EXAS (-$8.29M), Portola Pharmaceuticals (-$7.43M), SGEN (-$6.35M).
- Sold out of its positions in Alder Biopharmaceuticals, BIIB, CSII, CERS, Coherus Biosciences, Ikang Healthcare Group-, IMMU, PLX, SGEN, SYK. Ultragenyx Pharmaceutical.
- Sectoral Asset Management was a net seller of stock by $31.88M.
- Sectoral Asset Management has $831.39M in assets under management (AUM), growing by 13.02%.
Companies in the Sectoral Asset Management portfolio as of March 2019 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 5.55 | 3.39M | -32% | 13.60 |
| Aerie Pharmaceuticals | 4.80 | 839954 | -25% | 47.50 |
| Alnylam Pharmaceuticals (ALNY) | 4.40 | 391041 | -21% | 93.45 |
| Apellis Pharmaceuticals Inc | 4.05 | 1.73M | -20% | 19.50 |
| Teladoc | 3.96 | 591481 | -6% | 55.60 |
| Shockwave Med Inc | 3.42 | 849811 | NEW | 33.47 |
| Gilead Sciences (GILD) | 3.41 | 436140 | +2% | 65.01 |
| Array BioPharma (ARRY) | 2.67 | 909968 | -57% | 24.38 |
| Portola Pharmaceuticals | 2.54 | 609357 | -26% | 34.70 |
| Novartis AG (NVS) | 2.36 | 204046 | -4% | 96.14 |
| Pfizer (PFE) | 2.14 | 419126 | 42.47 | |
| Ptc Therapeutics I | 2.10 | 463137 | +98% | 37.64 |
| Celgene Corporation (CELG) | 2.04 | 179700 | -54% | 94.34 |
| Hill-Rom Holdings (HRC) | 2.02 | 158799 | 105.86 | |
| Wright Medical Group Nv | 1.90 | 501272 | -6% | 31.45 |
| Ra Pharmaceuticals | 1.85 | 686513 | -14% | 22.40 |
| Sarepta Therapeutics | 1.84 | 128098 | NEW | 119.19 |
| Evolent Health | 1.82 | 1.20M | +104% | 12.58 |
| Eli Lilly & Co. (LLY) | 1.74 | 111465 | +7% | 129.76 |
| Global Blood Therapeutics In | 1.74 | 273341 | -3% | 52.93 |
| Assembly Biosciences | 1.70 | 715798 | +354% | 19.69 |
| Collegium Pharmaceutical Inc Common Stock Usd | 1.70 | 934334 | -19% | 15.14 |
| Merck & Co (MRK) | 1.65 | 164700 | NEW | 83.17 |
| Acceleron Pharma | 1.51 | 269396 | +27% | 46.57 |
| Allergan | 1.50 | 84900 | NEW | 146.41 |
| Vocera Communications | 1.45 | 381579 | +44% | 31.63 |
| La Jolla Pharmaceuticl Com Par | 1.36 | 1.76M | 6.43 | |
| AtriCure (ATRC) | 1.27 | 393123 | +10% | 26.79 |
| Bristol Myers Squibb (BMY) | 1.26 | 218697 | -14% | 47.71 |
| R1 Rcm | 1.26 | 1.09M | 9.67 | |
| Medtronic | 1.14 | 103951 | -11% | 91.08 |
| Boston Scientific Corporation (BSX) | 1.12 | 241876 | 38.38 | |
| Insulet Corporation (PODD) | 1.04 | 90860 | -5% | 95.09 |
| Tandem Diabetes Care Inc | 1.04 | 135667 | -33% | 63.50 |
| UnitedHealth (UNH) | 1.03 | 34488 | -21% | 247.27 |
| Viewray | 1.00 | 1.12M | -6% | 7.39 |
| Obseva Sa | 0.97 | 628692 | +11% | 12.79 |
| Abbott Laboratories (ABT) | 0.94 | 97598 | 79.94 | |
| Albireo Pharma | 0.94 | 242978 | +5% | 32.21 |
| D Stemline Therapeutics | 0.92 | 596058 | +1434% | 12.85 |
| HMS Holdings (HMSY) | 0.91 | 254557 | +1953% | 29.61 |
| Forty Seven Inc | 0.91 | 466502 | NEW | 16.16 |
| BioMarin Pharmaceutical (BMRN) | 0.86 | 80321 | -12% | 88.83 |
| Unum Therapeutics Ord | 0.84 | 1.59M | +26% | 4.39 |
| Glycomimetics | 0.82 | 548007 | NEW | 12.46 |
| Savara | 0.79 | 896200 | +5% | 7.37 |
| Cigna Corp New | 0.79 | 40809 | -39% | 160.82 |
| ABIOMED (ABMD) | 0.77 | 22427 | 285.59 | |
| Irhythm Technologies Inc Com Added | 0.74 | 82600 | -15% | 74.96 |
| Zimmer Holdings (ZMH) | 0.73 | 47698 | +2172% | 127.70 |
| Intec Pharma Ltd shs added | 0.71 | 809000 | -26% | 7.33 |
| Nightstar Therapeutics Plc adr | 0.71 | 233711 | 25.37 | |
| Adamas Pharmaceuticals | 0.69 | 808924 | -28% | 7.11 |
| Meiragtx Holdings Plc | 0.67 | 320896 | -21% | 17.23 |
| Madrigal Pharmaceuticals | 0.64 | 42487 | +49% | 125.26 |
| Evelo Biosciences Inc | 0.63 | 651077 | +59% | 8.00 |
| Sage Therapeutics | 0.60 | 31600 | -14% | 159.05 |
| Inspire Med Sys Inc | 0.59 | 85900 | NEW | 56.78 |
| WellCare Health Plans (WCG) | 0.53 | 16251 | -16% | 269.77 |
| Fibrogen | 0.53 | 81260 | NEW | 54.34 |
| Agios Pharmaceuticals | 0.49 | 60000 | NEW | 67.43 |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.45 | 20271 | -44% | 183.96 |
| EXACT Sciences Corporation (EXAS) | 0.40 | 38400 | -71% | 86.61 |
| Spring Bk Pharmaceuticals In | 0.35 | 276656 | +9% | 10.49 |
| Proteostasis Therapeutics In | 0.31 | 2.05M | +29% | 1.26 |
| Johnson & Johnson (JNJ) | 0.30 | 17799 | 139.78 | |
| Urogen Pharma | 0.29 | 65063 | NEW | 36.93 |
| Molecular Templates Inc | 0.24 | 350000 | 5.81 | |
| Beigene | 0.17 | 10927 | -26% | 131.97 |
| Thermo Fisher Scientific (TMO) | 0.15 | 4549 | 273.69 | |
| Anthem | 0.12 | 3361 | 287.12 | |
| Hutchison China Meditech | 0.12 | 31628 | 30.57 | |
| Dr. Reddy's Laboratories (RDY) | 0.10 | 19697 | +8% | 40.51 |
| Becton, Dickinson and (BDX) | 0.09 | 3015 | 249.75 | |
| HCA HOLDINGS Inc | 0.08 | 5316 | 130.36 | |
| Dermira | 0.07 | 41902 | 13.56 | |
| Humana (HUM) | 0.06 | 1841 | 266.16 | |
| Kalvista Pharmaceuticals | 0.06 | 17551 | 28.60 | |
| Universal Health Services (UHS) | 0.05 | 2881 | 133.63 | |
| Spark Therapeutics | 0.05 | 3554 | NEW | 113.96 |
| Blueprint Medicines | 0.04 | 4184 | 80.07 | |
| Zai Lab Ltd adr added | 0.04 | 12589 | 29.55 | |
| Centene Corporation (CNC) | 0.03 | 4180 | +100% | 53.11 |
| Acelrx Pharmaceuticals Inc | 0.03 | 73778 | 3.48 | |
| Chemocentryx | 0.03 | 17811 | 13.87 | |
| Myokardia | 0.03 | 4051 | NEW | 52.09 |
| Sierra Oncology | 0.03 | 140376 | -30% | 1.71 |
| ImmunoGen (IMGN) | 0.02 | 58013 | -57% | 2.71 |
| Antares Pharma (AIS) | 0.02 | 47280 | 3.02 | |
| Mei Pharma | 0.02 | 44539 | 3.08 | |
| Cytokinetics | 0.02 | 15582 | 8.09 | |
| Revance Therapeutics | 0.02 | 11234 | 15.76 | |
| Quotient Ltd shs | 0.02 | 17649 | 9.01 | |
| Kura Oncology | 0.02 | 11800 | 16.61 | |
| Protagonist Therapeutics Inc Com stock | 0.02 | 11400 | 12.54 | |
| Biohaven Pharmaceutical Holding | 0.02 | 3900 | NEW | 51.54 |
| Biolinerx Ltd-spons Adr | 0.01 | 178297 | -10% | 0.43 |
| Tetraphase Pharmaceuticals | 0.01 | 39821 | 1.33 | |
| Marinus Pharmaceuticals | 0.01 | 16800 | 4.17 | |
| Abeona Therapeutics | 0.01 | 12681 | 7.33 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.01 | 25447 | 2.63 | |
| Cytomx Therapeutics | 0.01 | 10058 | 10.74 | |
| Corvus Pharmaceuticals | 0.01 | 12594 | 4.05 | |
| Aeglea Biotherapeutics | 0.01 | 12954 | 8.03 | |
| Nabriva Therapeutics | 0.01 | 38255 | 2.43 | |
| Clearside Biomedical | 0.00 | 25959 | 1.39 |
Download CSV 
Past 13F-HR SEC Filings by Sectoral Asset Management
- Sectoral Asset Management 2018 Q4 filed Feb. 12, 2019
- Sectoral Asset Management 2018 Q3 filed Nov. 14, 2018
- Sectoral Asset Management 2018 Q2 filed Aug. 13, 2018
- Sectoral Asset Management 2018 Q1 filed May 15, 2018
- Sectoral Asset Management 2017 Q4 filed Feb. 13, 2018
- Sectoral Asset Management 2017 Q3 filed Nov. 14, 2017
- Sectoral Asset Management 2017 Q2 filed Aug. 14, 2017
- Sectoral Asset Management 2017 Q1 filed May 15, 2017
- Sectoral Asset Management 2016 Q4 filed Feb. 10, 2017
- Sectoral Asset Management 2016 Q3 filed Nov. 10, 2016
- Sectoral Asset Management 2016 Q2 filed Aug. 12, 2016
- Sectoral Asset Management 2016 Q1 filed May 13, 2016
- Sectoral Asset Management 2015 Q4 filed Feb. 12, 2016
- Sectoral Asset Management 2015 Q3 filed Nov. 13, 2015
- Sectoral Asset Management 2015 Q2 filed Aug. 13, 2015
- Sectoral Asset Management 2015 Q1 filed May 14, 2015
- Sectoral Asset Management 2014 Q4 filed Feb. 13, 2015
- Sectoral Asset Management 2014 Q3 filed Nov. 13, 2014
- Sectoral Asset Management 2014 Q2 filed Aug. 14, 2014